𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Guidelines for development of diagnostic markers in bladder cancer

✍ Scribed by Peter J. Goebell; Susan L. Groshen; Bernd J. Schmitz-Dräger


Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
258 KB
Volume
26
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Development of chemopreventive agents fo
✍ Gary J. Kelloff; Charles W. Boone; Winfred F. Malone; Vernon E. Steele; Linda A. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 943 KB

The term cancerchemoprevention refers to the prevention or prolongation of carcinogenesis by intervention with drugs prior to the malignant (i.e., invasive) stage. The development of chemopreventive drugs is the major objective of the Chemoprevention Branch of the National Cancer Institute. Neoplast

Genetic alterations as clonal markers fo
✍ Li Mao 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 551 KB

Bladder cancer i s the result of a clonal expansion of cancer cells in which multiple genetic alterations have accumulated. Point mutations of the p53 gene are frequently observed in bladder cancer. Loss of a retinoblastoma (Rb) allele is also common in bladder cancer. Recent data have shown frequen